TANK and central nervous system cancer: Furthermore, we found that gliomas with high levels of TANK consistently exhibited higher immune and stromal scores than those with low levels of TANK in four cohorts (P < 0.05, Figure 3C), indicating that TANK may regulate immune and stromal cells.